21 CFR Subpart A - General Provisions
prev | next
- § 310.3 Definitions and interpretations.
- § 310.4 Biologics; products subject to license control.
- § 310.6 Applicability of “new drug” or safety or effectiveness findings in drug efficacy study implementation notices and notices of opportunity for hearing to identical, related, and similar drug products.